US Stock MarketDetailed Quotes

Inhibrx Biosciences (INBX)

Watchlist
  • 117.950
  • +9.300+8.56%
Close May 13 16:00 ET
  • 117.950
  • 0.0000.00%
Post 16:10 ET
1.72BMarket Cap-13.05P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Inhibrx Biosciences (INBX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
550.00%1.3M
0
0
1,200.00%1.3M
0
-88.89%200K
-93.88%100K
0
233.33%100K
0
Operating revenue
550.00%1.3M
--0
--0
1,200.00%1.3M
--0
-88.89%200K
-93.88%100K
--0
233.33%100K
--0
Cost of revenue
Gross profit
Operating expense
-58.89%136.33M
-38.19%30.92M
-27.75%33.81M
-82.18%28.69M
-41.89%42.9M
50.05%331.65M
-44.37%50.03M
1.85%46.8M
289.18%161M
86.70%73.83M
Selling and administrative expenses
-81.87%23.12M
-66.81%5.4M
-33.24%5.28M
-93.12%6.42M
-39.60%6.02M
333.96%127.5M
107.57%16.26M
0.19%7.9M
1,185.50%93.37M
86.99%9.97M
-General and administrative expense
-81.87%23.12M
-66.81%5.4M
-33.24%5.28M
-93.12%6.42M
-39.60%6.02M
333.96%127.5M
107.57%16.26M
0.19%7.9M
1,185.50%93.37M
86.99%9.97M
Research and development costs
-44.52%113.03M
-24.03%25.35M
-26.63%28.54M
-67.08%22.27M
-42.25%36.88M
6.32%203.74M
-59.35%33.37M
2.20%38.89M
98.30%67.63M
86.66%63.85M
Depreciation amortization depletion
-55.69%179K
----
----
----
----
--404K
----
----
----
----
-Depreciation and amortization
-55.69%179K
----
----
----
----
--404K
----
----
----
----
Operating profit
59.26%-135.03M
38.06%-30.92M
27.75%-33.81M
82.98%-27.39M
41.89%-42.9M
-51.19%-331.45M
43.45%-49.93M
-2.12%-46.8M
-289.22%-160.9M
-86.70%-73.83M
Net non-operating interest income expense
-82.16%-4.65M
-193.46%-1.87M
-148.34%-1.4M
61.18%-1.02M
92.54%-360K
87.20%-2.55M
156.79%2M
149.65%2.89M
52.29%-2.62M
-4.83M
Non-operating interest income
-31.00%7.55M
-34.45%1.31M
-38.35%1.78M
-22.51%2.12M
-29.51%2.33M
-8.20%10.94M
-57.35%2M
24.44%2.89M
13.55%2.74M
--3.3M
Non-operating interest expense
-9.60%12.2M
--3.19M
--3.18M
-41.41%3.14M
-66.92%2.69M
-57.63%13.49M
--0
--0
-32.18%5.36M
--8.13M
Other net income (expense)
-100.02%-381K
-165.00%-39K
-212.20%-46K
-100.01%-246K
15.25%-50K
348,647.07%2.02B
137.97%60K
130.37%41K
931,681.11%2.02B
15.71%-59K
Special income (charges)
--0
--0
--0
--0
----
--2.02B
--0
--0
--2.02B
----
-Less：Restructuring and merger&acquisition
--0
--0
--0
--0
----
---2.02B
--0
--0
---2.02B
----
Other non- operating income (expenses)
-608.00%-381K
-165.00%-39K
-212.20%-46K
-845.45%-246K
15.25%-50K
112.93%75K
137.97%60K
130.37%41K
115.21%33K
15.71%-59K
Income before tax
-108.30%-140.05M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
803.97%1.69B
47.96%-47.87M
15.30%-43.86M
4,049.27%1.86B
-98.71%-78.71M
Income tax
0.00%2K
0
0
0.00%2K
0
-33.33%2K
0
0
-60.00%2K
0
Earnings from equity interest net of tax
----
----
----
----
----
--0
----
----
----
----
Net income
-108.30%-140.06M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
799.19%1.69B
48.86%-47.87M
15.30%-43.86M
4,048.85%1.86B
-98.71%-78.71M
Net income continuous Operations
-108.30%-140.06M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
799.19%1.69B
48.86%-47.87M
15.30%-43.86M
4,048.85%1.86B
-98.71%-78.71M
Minority interest income
Net income attributable to the parent company
-108.30%-140.06M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
799.19%1.69B
48.86%-47.87M
15.30%-43.86M
4,048.85%1.86B
-98.71%-78.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-108.30%-140.06M
31.40%-32.83M
19.62%-35.26M
-101.54%-28.65M
44.97%-43.31M
799.19%1.69B
48.86%-47.87M
15.30%-43.86M
4,048.85%1.86B
-98.71%-78.71M
Basic earnings per share
-107.93%-9.04
31.72%-2.11
19.72%-2.28
-101.46%-1.85
49.34%-2.8
772.70%114.01
52.99%-3.09
21.90%-2.84
3,946.92%127.1
-98.71%-5.5269
Diluted earnings per share
-108.03%-9.04
31.72%-2.11
19.72%-2.28
-101.47%-1.85
49.34%-2.8
764.50%112.62
52.99%-3.09
21.90%-2.84
3,897.89%125.48
-98.71%-5.5269
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 550.00%1.3M001,200.00%1.3M0-88.89%200K-93.88%100K0233.33%100K0
Operating revenue 550.00%1.3M--0--01,200.00%1.3M--0-88.89%200K-93.88%100K--0233.33%100K--0
Cost of revenue
Gross profit
Operating expense -58.89%136.33M-38.19%30.92M-27.75%33.81M-82.18%28.69M-41.89%42.9M50.05%331.65M-44.37%50.03M1.85%46.8M289.18%161M86.70%73.83M
Selling and administrative expenses -81.87%23.12M-66.81%5.4M-33.24%5.28M-93.12%6.42M-39.60%6.02M333.96%127.5M107.57%16.26M0.19%7.9M1,185.50%93.37M86.99%9.97M
-General and administrative expense -81.87%23.12M-66.81%5.4M-33.24%5.28M-93.12%6.42M-39.60%6.02M333.96%127.5M107.57%16.26M0.19%7.9M1,185.50%93.37M86.99%9.97M
Research and development costs -44.52%113.03M-24.03%25.35M-26.63%28.54M-67.08%22.27M-42.25%36.88M6.32%203.74M-59.35%33.37M2.20%38.89M98.30%67.63M86.66%63.85M
Depreciation amortization depletion -55.69%179K------------------404K----------------
-Depreciation and amortization -55.69%179K------------------404K----------------
Operating profit 59.26%-135.03M38.06%-30.92M27.75%-33.81M82.98%-27.39M41.89%-42.9M-51.19%-331.45M43.45%-49.93M-2.12%-46.8M-289.22%-160.9M-86.70%-73.83M
Net non-operating interest income expense -82.16%-4.65M-193.46%-1.87M-148.34%-1.4M61.18%-1.02M92.54%-360K87.20%-2.55M156.79%2M149.65%2.89M52.29%-2.62M-4.83M
Non-operating interest income -31.00%7.55M-34.45%1.31M-38.35%1.78M-22.51%2.12M-29.51%2.33M-8.20%10.94M-57.35%2M24.44%2.89M13.55%2.74M--3.3M
Non-operating interest expense -9.60%12.2M--3.19M--3.18M-41.41%3.14M-66.92%2.69M-57.63%13.49M--0--0-32.18%5.36M--8.13M
Other net income (expense) -100.02%-381K-165.00%-39K-212.20%-46K-100.01%-246K15.25%-50K348,647.07%2.02B137.97%60K130.37%41K931,681.11%2.02B15.71%-59K
Special income (charges) --0--0--0--0------2.02B--0--0--2.02B----
-Less：Restructuring and merger&acquisition --0--0--0--0-------2.02B--0--0---2.02B----
Other non- operating income (expenses) -608.00%-381K-165.00%-39K-212.20%-46K-845.45%-246K15.25%-50K112.93%75K137.97%60K130.37%41K115.21%33K15.71%-59K
Income before tax -108.30%-140.05M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M803.97%1.69B47.96%-47.87M15.30%-43.86M4,049.27%1.86B-98.71%-78.71M
Income tax 0.00%2K000.00%2K0-33.33%2K00-60.00%2K0
Earnings from equity interest net of tax ----------------------0----------------
Net income -108.30%-140.06M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M799.19%1.69B48.86%-47.87M15.30%-43.86M4,048.85%1.86B-98.71%-78.71M
Net income continuous Operations -108.30%-140.06M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M799.19%1.69B48.86%-47.87M15.30%-43.86M4,048.85%1.86B-98.71%-78.71M
Minority interest income
Net income attributable to the parent company -108.30%-140.06M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M799.19%1.69B48.86%-47.87M15.30%-43.86M4,048.85%1.86B-98.71%-78.71M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -108.30%-140.06M31.40%-32.83M19.62%-35.26M-101.54%-28.65M44.97%-43.31M799.19%1.69B48.86%-47.87M15.30%-43.86M4,048.85%1.86B-98.71%-78.71M
Basic earnings per share -107.93%-9.0431.72%-2.1119.72%-2.28-101.46%-1.8549.34%-2.8772.70%114.0152.99%-3.0921.90%-2.843,946.92%127.1-98.71%-5.5269
Diluted earnings per share -108.03%-9.0431.72%-2.1119.72%-2.28-101.47%-1.8549.34%-2.8764.50%112.6252.99%-3.0921.90%-2.843,897.89%125.48-98.71%-5.5269
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -